Home / Deeper

Half-life: why DAC, PEG and fatty acid tails exist

The biggest problem with peptides is not whether they work, but how long they exist. Nearly every variant you meet is an attempt to solve that.

Two ways to disappear

A peptide leaves the bloodstream in two ways. Enzymes cut the chain, and the kidneys filter it out. Which of the two goes fastest depends on size: small molecules go mainly through the kidneys, larger ones mainly through enzymes.

That explains why a strategy that works for one peptide does nothing for another. You have to know which route is the culprit.

Trick 1: replace an amino acid

Enzymes cut at recognisable spots. Replace the amino acid at such a spot with a variant the enzyme does not know, and the scissors no longer work. This is what happens in every GLP-1 analogue at the point where DPP-4 would cut.

Gain: from minutes to hours. Cost: you change the molecule, so you have to check it still fits the receptor as well as before.

Trick 2: a cap on the end

Some enzymes start at the beginning or the end of a chain. An acetyl group at the front, or an amide at the back, makes those ends unrecognisable. That is exactly the difference between Semax and N-Acetyl Semax.

Gain: modest but cheap. Cost: almost none; the molecule barely changes.

Trick 3: a fatty acid tail

Hang a fatty acid on the chain and that tail clamps onto albumin, a protein swimming abundantly in the blood. While the peptide hangs there it is too big for the kidneys and enzymes struggle to reach it. Semaglutide and tesamorelin work this way.

Gain: the largest of all, from hours to days. Cost: the molecule becomes fattier and so harder to dissolve in water. That is why these substances in particular sometimes need acetic acid.

Trick 4: a PEG coat

PEG is a synthetic chain draped around the peptide like a coat. That coat keeps enzymes at bay and makes the whole bigger, so it will not pass the kidneys. PEG-MGF is the example in this range.

Gain: large and predictable. Cost: the coat can get in the receptor’s way, so the molecule often becomes less potent while lasting longer.

Longer is not always better

That last point is the heart of this article. A longer half-life always looks like a gain, but not every system is built on a constant signal. The growth hormone axis works in pulses, and a substance that erases those pulses changes the system it set out to study.

So the question is never which variant lasts longest, but which variant fits what you want to see.

Updated 2026-10-03

Read next